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Abstract  
Purpose : The aim of the study is to assess   prevalence and contributing factors of neonatal jaundice among 
neonates admitted to neonatal intensive care unit at St. Paul Hospital Millennium Medical College, from January 
1 to December 31, 2018. Addis Ababa, Ethiopia, 2019.  Methods : A cross-sectional   institution   based   
retrospective study was conducted on 338 samples selected using systematic random sampling taken from a one-
year retrospective review of medical records. These neonates were admitted to neonatal intensive care unit at St. 
Paul Hospital Millennium Medical College from January 1 to December 31, 2018. Addis Ababa Ethiopia. Data 
was collected by a structured checklist format then entered and analyzed using SPSS 23. Bivariate and multivariate 
logistic regressions were conducted to identify contributing factors of neonatal jaundice considering p-value less 
than 0.05. Results : Among 338 total neonates enrolled under this study the prevalence of neonatal jaundice was 
found to be [p=45 (13.3%), CI=1.83-1.90].  The factors which show statistically significant relationship between 
hyperbilirubinemia were inadequate breast feeding with AOR = 30.770 (CI=9.974-94.929), followed by presence 
of cephalhematoma AOR=9.627(CI=2.651-34.958) and neonatal infection or sepsis having AOR =4.690 
(CI=1.529-14.390), maternal age AOR=.092 (CI=.016-.528), and breast milk jaundice AOR=.026 (CI=.003-.206) 
both do not reach statistical significance. Conclusion : By identifying the contributing factors earlier, we may be 
able to modify them and reduce the need for neonatal intensive care unit admissions for Neonatal 
Hyperbilirubinemia.  
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Introduction  
Neonatal Hyperbilirubinemia is the yellowish discoloration of the skin, sclera and mucous membranes resulting 
from deposition of bilirubin. It happens when a serum bilirubin greater than 85 μmol/L (5 mg/dl).1     In a proportion 
of infants, jaundice may become severe, typically with total plasma/serum bilirubin (TSB) ≥20mg/dL or 
342μmol/L, necessitating prompt hospitalization for phototherapy and/or exchange transfusion (ET) to halt 
potential progression to acute bilirubin encephalopathy (ABE) or kernicterus.2, 
Neonatal hyperbilirubinemia (NH) is associated with a variety of conditions. It poses a direct risk of 
permanent neurological sequel due to neurotoxicity resulting in hearing loss and intellectual deficits. Therefor the 
early identification of neonates who are at a greater risk of developing severe neonatal hyperbilirubinemia is of 
paramount importance to preventing brain damage.3 Neonatal jaundice(NNJ) is very common and is present in 60% 
of term babies and up to 80% of premature babies.4 The known risk factors for the occurrence of neonatal 
hyperbilirubinemia are exclusive breast feeding, ABO incompatibility, premature birth, infection, 
cephalohematoma, and asphyxia.5  
 Even though United Nations Children's Fund (UNICEF) targets to decrease in death rates occurring at 
neonatal age, Global Burden of Disease (GBD) indicates that first attempt to estimate the burden of severe NNJ 
estimated to affect 481,000 late-preterm and term neonates annually, with 114, 000 dying and >63, 000 surviving 
with moderate or severe long-term neurologic impairments. 6,13 That’s why we need to further research and 
interventions to put the alarming problem under control.   
Every year approximately 10.8 million children under the age of five years die worldwide and 38% of these 
mortalities are said to occur in the first month of life.8 Recent global study estimates that about 1.1 million babies 
would develop hyperbilirubinemia with or without bilirubin encephalopathy worldwide yearly. The global burden 
of neonatal hyperbilirubinemia impacts mostly the world’s poorest countries (low-income countries), especially 
in South Asia and sub-Saharan Africa. Latin America, sub- Saharan Africa and South Asia account for 4%, 32% 
and 39% of cases of extreme hyperbilirubinemia (total bilirubin exceeding 428 μmol/L) respectively.9 
According to a report by GBD in 2016, Lack of facilities for rapid, routine bilirubin determination or 
suboptimal irradiance (<8–10 μW/cm2/nm) from poorly maintained phototherapy devices are levels of delay for 
effective intervention that result in higher rates of avoidable and potentially harmful exchange transfusion as well 
as bilirubin induced mortality in developing countries. It also mentions home deliveries do play a role in late 
detection and treatment of neonatal jaundice.6 
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In Africa, neonatal jaundice is a common pediatric problem particularly in West Africa that is associated with 
sickness and death.10 A study conducted in Southeast Nigeria found that neonatal jaundice accounted for 35% of 
hospital admissions and 9.7% of newborns developed kernicterus.11 In Ethiopia, according to a study done in Tikur 
Anbessa Hospital, among 356 total neonates, 160(44.9%) of them were diagnosed for hyperbilirubinemia. From 
these, 11(6.9%) neonates developed bilirubin encephalopathy.12  
As the above studies indicate bilirubin induced mortality is highly prevalent in developing countries, in which 
our country belongs to. So the main aim of our study is to determine its prevalence and factors leading to this 
problem in SPHMMC and to look ways to decrease associated morbidity, severe complications and mortalities 
which can easily be treated only if identified and treated earlier.  
Neonatal jaundice is among the leading causes of neonatal morbidity and mortality in Ethiopia.12 Even though 
neonatal jaundice is not totally preventable, with early detection and treatment it is possible to avert irreversible 
complications. There are limited studies done in Ethiopia on neonatal Jaundice. Therefore, this study focused on 
the assessment of recent prevalence of neonatal jaundice and factors contributing in NICU of SPHMMC, which 
help for better preparedness and resource allocation in the unit. The study findings also can help policy makers 
and other sectors working on neonatal health to plan for early detection and treatment. The study also helps as a 
scientific reference for further related studies. 
 
Material and methods 
Study area, period and design 
Institution based, retrospective cross-sectional study was conducted among neonates admitted to neonatal intensive 
care unit (NICU) from January 1 to December 31, 2018 at St Paul’s Hospital Millennium Medical College 
(SPHMMC)., Addis Ababa, Ethiopia The study was conducted on the period of July 1- July 15, 2019 using a one-
year retrospective data. 
Source Population  
The source population includes all neonates admitted to NICU of SPHMMC from January 1 to December 31, 2018.  
Study population  
 All randomly selected neonates admitted to NICU of SPHMMC during the study period.  
Sample Size and Sample Size Determination   
Sample size for the study was determined by using single population formula, by taking the proportion of previous 
similar study conducted at Tikur Anbessa hospital, Addis Ababa, 2018.12 Sample size is calculated by using single 
population proportion formula by taking the proportion (p) of 44.9%, with CI=95%, margin of error =0.05 with a 
correction formula used to determine the sample size.  
So, n f =338.   
Sampling Technique  
To sort out our final sample participants   n f =338, we used systematic random sampling with a formula K=N/n 
where,  
N=the total number of neonates admitted to NICU during the study period, and n=the population under study as, 
K=3067/338= 9  
 As K=, we selected every 9 th chart and found 338 charts to be reviewed, after selecting the first serial number 
using a lottery method.  
Operational definitions  
 Neonatal jaundice: is a yellowish discoloration of a newborns skin and eyes.  
 Fetal Asphyxia: A complete lack or inadequate supply of oxygen by a baby before birth. 
 Breast Milk Jaundice: Jaundice due certain substance in breast milk which blocks bilirubin breakdown.  
 Breast Feeding Jaundice: Jaundice caused by inadequate intake of breast milk.  
Eligibility Criteria    
Inclusion criteria  
All neonates admitted in NICU of SPHMMC between   January 1 to December 31, 2018, with complete 
documentation of History, physical examination and management.  
Exclusion Criteria  
All neonates admitted in NICU of SPHMMC between September 1 and August 30 with incomplete documentation 
of History, physical examination and management.  
Data collection methods  
Data was collected using check list prepared by Investigators after reviewing related literatures.   It has four parts 
which was filled by reviewing chart of medical records of patients. The checklist had parts to be completed as 
sociodemographic characteristics, maternal information, and neonatal information. It also contains associated 
medical information of the newborn which helps to trace related factors.   
Data quality assurance  
The quality of data was assured by using careful data collection procedures which was checked by supervisors for 
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completeness, consistency and accuracy. Pretest was conducted on 5 % of the sample before the actual data 
collection period. Corrective measures were taken, when necessary by the research team, to ensure a common 
understanding of each record.  
Data processing and Analysis  
Data was entered into SPSS 23 after checking for completeness then analyzed and expressed using descriptive 
methods and logistic regression was applied to sort out relationship between variables. Using binary logistic 
regression variables were identified for having association (p<0.05) with neonatal jaundice   and these significant 
factors were further analyzed with multivariate logistic regressions to find out a statistically significant association.  
Ethical Considerations   
Ethical clearance was obtained from St Paul’s Hospitals Millennium Medical College Institutional Review Board 
to conduct the research. Since the study is record review confidentiality about patient profile and other ethical 
aspects were strictly maintained throughout the study and then after. Additional Consent was also granted from 
the appropriate personnel in the record office. 
 
Results 
Socio demographic characteristics of the study population  
 The study population consisted of 338 (n=338) neonates admitted in St. Paul Hospital Millennium medical college. 
The study involved a one-year retrospective record review. Out of the 338 cases analyzed, 252 (74.6%) were males. 
Most of births is through spontaneous Vaginal delivery, 274 (81.1%) Majority of the neonates had no infection 
310 (91.7%) (Table 1).  
Table 1: Socio-demographic and clinical characteristics of the study population at SPHMMC, 2018  
Characteristics Category  Number (%)  
  
Gravidity  
Primigravida  118 (34.9%)  
Multigravida  220 (65.1%)  
  
PPROM  
No PPROM  313 (92.6%)  
Had PPROM  25(7.4%)  
  
  
Mode of delivery  
Cesarean section  48 (14.2%)  
Spontaneous vaginal  274 (81.1%)  
Instrument assisted  16 (4.7%)  
  
Newborns sex  
Male  252 (74.6%)  
Female  86 (25.4%)  
  
Gestational age  
Preterm (<37wks)  8 (2.4%)  
Term (37-42 wks.)  317 (93.8%)  
Post term (>42 wks.)  13 (3.8%)  
  
Infection  
No infection  310 (91.7%)  
Has infection  28 (8.3%)  
Maternal Age 
The age of mothers is highly concentrated around the age 25-29 years which were 156 (46.25%) (Figure 1). 
Figure: 1 Maternal age distribution who delivered at SPHMMC in 2018.  
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Prevalence of neonatal jaundice 
The finding of this study shows that the prevalence of neonatal jaundice is [p= 13.3% (CI=1.83-1.90)], which were 
diagnosed and confirmed by laboratory to have a raised bilirubin level (Figure 2). 
Figure: 2 Prevalence of neonatal jaundice among neonates admitted at SPHMMC in 2018. 
  
Contributing factors of Neonatal Jaundice 
Maternal age, infection, inadequate breast feeding, cephalhematoma and breast milk jaundice were included in the 
final model for the contributing factors of neonatal jaundice. The multivariate logistic regression reveled that 
inadequate breast feeding (breast feeding jaundice) AOR = [30.770 (9.974-94.929)] is the major contributor for 
neonatal jaundice followed by cephalhematoma AOR= [9.627(2.651-34.958)] and neonatal infection having an 
AOR= [4.690 (1.529-14.390)]. Conversely, maternal age group of 30-35 years AOR= [0.092 (.016-.528)]  and 25-
29 years AOR=[0.250(.070-.900)] have less likelihood of contributing to neonatal jaundice. The other factors such 
as breast milk jaundice [AOR=.026 (.003.206)] and maternal age [AOR=.092 (.016-.528)] do not reach statistical 
significance level (Table 2).    
Table 2: Contributing factors of neonatal jaundice in NICU at SPHMMC, 2018 
S/N  Variable  Jaundice   COR (95% CI) AOR (95% CI)  PV  
  
1  
Maternal Age  No  Yes       
15-19 Years  13 (3.8%)  5 (1.5%)  0.0 0.0    
20-24 Years  72 (21.3%)  15 (4.4%)  .542 (.168-1.748) .356(.092-1.373)  .134  
25-29 Years  139 (41.1%)  17 (5.0%)  .318 (.101-1.002) .250(.070-.900)* .034  
30-35 Years  61 (18.0%)  5 (1.5%)  .213 (.054-.844) .092(.016-.528)* .007  
Above 35 Years  8 (2.4%)  3 (0.9%)  .975 (.182-5.235) .565(.069-4.643)  .596  
  
2  
Infection           
No  278 (82.2%)  32 (9.5%)  0.0  0.0    





        
No  288 (85.2%)  26 (7.7%)  0.0  0.0    
Yes  5 (1.5%)  19 (5.6%)  42.094 (14.529-121.950)  30.770 (9.974-94.929) ** .000  
    4  Cephalhematoma           
No  285 (84.3%)  37(10.9%)  0.0  0.0    
Yes  8 (2.4%)  8 (2.4%)  9.627(2.651-34.958)  9.627(2.651-34.958) * .001  
  
5  
Breast Milk Jaundice           
No  291 (86.1%)  41(12.1%)  0.0  0.0    
Yes  2 (0.6%)  4 (1.2%)  .070 (.013-.397)  .026 (.003-.206)  .001  
*: Significant association at p-value < 0.05, **: Significant association at p-value < 0.001 
 
Discussion 
The findings of this study revealed that the prevalence of neonatal jaundice is [p=13.3% (CI=1.83-1.90)] which is 




 Non Jaundiced 
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was 44.9% and another study at Mekelle city, both in Ethiopia public hospitals, reported the prevalence of neonatal 
jaundice to be 37.3%. Additionally, Africa studies of south east Nigeria and Kenyan district hospital both report 
relatively higher prevalence of 35%. This variation might be linked with the fact that differences do appear among 
study designs and study areas we have selected for the study.   
The contributing   factors identified in this study were inadequate breast feeding (breast feeding jaundice) 
[AOR =30.770 (9.974-94.929)] meaning inadequately fed infants have thirty times likelihood developing neonatal 
jaundice than well fed infants, followed by cephalhematoma [AOR=9.627(2.651-34.958)] , showing babies having 
cephalhematoma after instrumental delivery are nine fold at risk of developing jaundice than without 
cephalhematoma ,and neonatal infection or sepsis having an [AOR=4.690 (1.529-14.390)] ,demonstrating 
neonates with infection or sepsis are four times  likely to have   jaundice  than those who don’t have sepsis.   
Institution based cross-sectional study conducted from February to April 2016 at Mekelle city public hospitals 
states that the odds of neonatal jaundice among neonates who had sepsis was 2.6 times higher compared with those 
neonates without sepsis [AOR = 2.64; 95% CI (1.15-6.05)] which had comparable result with the finding of this 
study, neonatal infection or sepsis having an [AOR=4.690 (1.529-14.390)].  
The etiologic factors of Neonatal Hyperbilirubinemia according to the study at Black Lion Hospital are ABO 
Incompatibility (35.6%), sepsis (18.8%), breast feeding (10%) and Prematurity (8.1%). Breast feeding jaundice 
demonstrated a strong significant association in our study [AOR =30.770 (9.974-94.929)] which comprises 10% 
of the etiologic factors of the study at Black Lion Hospital, Ethiopia. 
In the similar cross-sectional study done on national district hospital, Bloemfontein, South Africa normal 
vaginal delivery was the only risk factor associated with neonatal jaundice even if the majority of babies included 
in this study were born via C-section (64.6%). Normal vaginal delivery was associated with neonatal jaundice 
statistically, (p = 0.04) and the use of oxytocin was not associated with a higher incidence of neonatal jaundice (p 
= 0.44)] which is seen in our study that shows spontaneous vaginal delivery having significant association during 
bivariate analysis with neonatal jaundice [P=.007, CI= (1.319-6.011)] and also oxytocin use [P=.036 (CI=1.055-
5.150)] though both do not reach statistical significance during multivariate analysis.  
 
Conclusion 
As the findings of this research indicate, the prevalence of neonatal jaundice was found to be 13.3 % and the major 
contributors were breast feeding jaundice followed by cephalhematoma and neonatal infection. So effort has to be 
made to decrease the prevalence of neonatal jaundice due these preventable factors. 
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